Body Asymmetries in Athletes and Injury Risk (TELASI)

November 1, 2022 updated by: Nejc Sarabon, University of Primorska

Retrospective and Prospective Analysis of Asymmetries as Injury Risk Factors in Different Athletes

The study will assess the associations between various asymmetries (strength, flexibility, balance, etc.) in different athletes. After the measurements, injury occurrence will be tracked prospectively for 1 year, and retrospective analysis will be performed as well. The main aim of the study is to determine the asymmetries that impose the biggest injury risk for athletes.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

So far, the studies in the area of sport science have not thoroughly investigated the interrelations between different types or levels of body asymmetries, or determined the predictive power of asymmetries regarding injury risk. The conduction of this study will produce several original outputs. In short, the participants will be assessed for body asymmetries, and injury occurrence will be tracked both retrospectively and prospectively.

Participants:

  • athletes of different sports (not predefined)
  • not currently injured
  • no non-communicable diseases
  • participates in sport for at least 2 years
  • participates in competitive play / matches

Test battery:

The first part of our test battery will include the measurements of the structural irregularities. We will place a special emphasis on potential limb length discrepancy and pelvic alignment in frontal plane. When a noticeable deviations are seen, additional measurements of anthropometric characteristics will ensue.

The second part of the tests will be designed to assess the asymmetries in motor abilities and function. The flexibility will be evaluated by assessing the passive range of motion in individual joints, using an electronic goniometer. We will include all motions that are performed in each joint (all major lower limb joints and trunk will be included). Each test will be repeated three times, with the best result (highest range of motion) taken as a final result.

The ability to maintain a still single-leg stance with open eyes will be measured to evaluate static stability (main outcome parameters: velocity, amplitude and frequency of the centre of pressure). The dynamic stability will be assessed using similar parameters, captured after the landing on the force plate.

Maximal strength and explosive strength will be measured in isometric conditions on purposely designed dynamometers. Maximal force and rates of force development on different time intervals will be recorded. The measurements will include the ankle (flexion and extension), the knee (flexion and extension), the hip (flexion, extension, abduction and abduction) and the trunk (flexion, extension, lateral flexion). Additionally, the eccentric strength of the knee flexors will be assessed.

The last part of the measurements will include kinematic and kinetic evaluation of complex cyclic (cycling, running) and acyclic (jumps, landings) movement patterns. Lateral asymmetries during cycling will be measured using a diagnostic tool that records the forces and torques on the pedal, and by kinematics systems for tracking the motion of body regions. The pedals record the behaviour of the pressure exerted on the pedals during cycling, enabling us to evaluate the technique of the pedalling (mechanical efficiency) and amplitude (power). The kinematic analysis track the motion of the body. Dynamic and kinematic parameters are interrelated and often change simultaneously. Biomechanical properties (kinematic and dynamic) of running and jumps/landings will be recorded with a full-body motion capture solution that allows unconstrained movement of the subject and wireless transmission of measured quantities. Based on the measured motion and the acquired ground reaction forces, and the dynamic model of the human body, we will be able to calculate joint torques.

Injury tracking:

  • purpose-made questionnaires, including type, severity and recurrence of injury
  • built based on previous questionnaires used in Sports Medicine

Main outcomes:

  • Injury rates in 1-year follow up and 1-year history
  • Odds ratios between groups, based on presence of asymmetries

Study Type

Observational

Enrollment (Actual)

1050

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Izola, Slovenia, 6310
        • University of Primorska, Faculty of Health Sciences
      • Ljubljana, Slovenia, 1000
        • University of Ljubljana, Faculty of sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Athletes at a competitive level, coming from different sports.

Description

Inclusion Criteria:

  • Included in competitive play
  • Is a professional athlete or participates in organized professional sports activities
  • Had a medical examination in previous year

Exclusion Criteria:

  • Present injuries
  • Recreational athletes
  • Any other significant diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Athletes
For Asymmetry measurement, the group will consist of 200 athletes of different sports (the proportion not strictly predefined) - track and field, racket sports, ball sports, other team sports, swimming, running, cycling, dancing, ice skating, etc.
There is no intervention, the study will prospectively assess associations between asymmetries and injury risk. Asymmetry measurement will be conducted, then injuries will be tracked.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury occurence
Time Frame: After 1-year
Injury occurrence in 1-year follow up
After 1-year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength asymmetries
Time Frame: Baseline
Strength asymmetries between the opposing muscles or opposing limbs, measured by dynamometry
Baseline
Balance asymmetries
Time Frame: Baseline
Balance asymmetries (body sway) in different type of stances, measured by bilateral force plates
Baseline
Flexibility asymmetries
Time Frame: Baseline
Flexibility asymmetries between the opposing limbs (Range of Motion)
Baseline
Anthropometric asymmetries
Time Frame: Baseline
Asymmetries in body segment lengths and girths
Baseline
Injury history
Time Frame: 1-year before the study
Injury occurrence in 1-year history
1-year before the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nejc Šarabon, PhD, University of Primorska, Faculty of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2018

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

August 30, 2021

Study Registration Dates

First Submitted

April 23, 2018

First Submitted That Met QC Criteria

April 25, 2018

First Posted (Actual)

May 8, 2018

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TELASI-PREVENT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe